☀️ 83% Doctors: AI Fights Burnout

Plus: Brain activity is watchable and listenable

Logo

Welcome to your briefing:

  • AI ROUNDUP: Google DeepMind forms a new org focused on AI safety

  • INDUSTRY ROUNDUP: A watershed moment for cancer therapies

  • WELLNESS BYTES: Brain activity is watchable and listenable

  • INSIGHTS CORNER: The AI drug race

  • TRIVIA: What challenges does AI face in achieving widespread adoption in healthcare, according to a report by WHO?

AI ROUNDUP

WATCH THIS

— ### —

  • Elon Musk says first Neuralink patient can control a computer mouse through thinking (Read More)

  • Google DeepMind forms a new org focused on AI safety (Read More)

  • Nvidia invested in 5 AI stocks. Here's the best of the bunch (Read More)*

  • Biden administration enters debate on open versus closed AI systems (Read More)

  • IBM & Cleveland Clinic explore using AI to identify cancer (Read More)

  • 83 percent of doctors say AI could help fight burnout (Read More)

  • Smash or pass? AI could soon predict your date’s interest via physiological cues (Read More)

  • Google DeepMind alumni unveil Bioptimus: Aiming to build first universal biology AI model (Read More)

  • Super-speedy sequencing puts genomic diagnosis in the fast lane (Read More)


    *not investment advice

INDUSTRY ROUNDUP

  • Biden admin commits $100M for women’s health research (Read More)

  • A watershed moment for cancer therapies has arrived (Read More)

  • Lawmakers grill VA, Oracle leaders over pharmacy-related patient safety issues (Read More)

  • Alabama health system pauses IVF treatments after court embryo ruling (Read More)

  • Healthcare in Latin America: What are consumers looking for? (Read More)

  • FDA adds boxed warning to CAR T-Cell therapies, but says benefits outweigh risks of secondary cancers (Read More)

  • Some New Jersey patients can’t access medicine due to insurance hurdles. A new law is trying to speed up the prior authorization process (Read More)

WELLNESS BYTES

  • Brain activity is now watchable and listenable (Read More)

  • An 83-year-old triathlete doctor who transformed his health in his 40s takes these 6 supplements every day (Read More)

  • The best foods to eat for a long life, according to longevity experts (Read More)

INSIGHTS CORNER

The AI drug race

CB Insights published a report on "20 tech trends to watch closely in 2024”. Today we’re spotlighting the race of AI drug discovery and the crucial role of small molecule drugs.

Here are the four standout charts that caught my eye:

small molecule drug approvals
AI boosting precision drug discovery
AI drug discovery schedule
Pharam AI Readiness index

— ### —

In-network insurance claims spike after surprise billing ban

Insurance claim chart

In a significant shift spotlighted by Axios and rooted in the No Surprises Act, a FAIR Health analysis reveals a marked increase in in-network insurance claims, indicating a potential rise in providers joining insurers' networks. The Act, designed to protect patients from unexpected out-of-network bills, seems to have catalyzed this change.

Key Insights:

  • Trend Analysis: Data from about 42 billion commercial insurance claims showed in-network care claims rising from 84% to 90% nationally since 2019, with a notable spike following the Act's implementation.

  • Specialties Impact: Specialties prone to surprise billing, including emergency medicine and anesthesiology, experienced significant in-network claim increases, highlighting the Act's direct effect on reducing patients' unexpected financial burdens.

  • Future Implications: This trend not only suggests an improvement in billing transparency but also sets a precedent for further research on healthcare billing practices in the wake of new federal and state legislation.

The analysis underscores the No Surprises Act's effectiveness in enhancing patient protection against surprise billing, reflecting a broader movement towards more transparent and fair healthcare billing practices.

AI TRIVIA

HEALTHCARE CONFERENCES

MARCH 

That’s all for today, follow me on Linkedin.

Support us by sharing our newsletter with your colleagues.

Until next time.